In:
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Vol. 46, No. 10 ( 2002-10), p. 3283-3285
Kurzfassung:
By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the Mycobacterium fortuitum group at ≤0.12 μg/ml and 90% of the Mycobacterium chelonae isolates at ≤4 μg/ml. Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria.
Materialart:
Online-Ressource
ISSN:
0066-4804
,
1098-6596
DOI:
10.1128/AAC.46.10.3283-3285.2002
Sprache:
Englisch
Verlag:
American Society for Microbiology
Publikationsdatum:
2002
ZDB Id:
1496156-8
SSG:
12
SSG:
15,3